Poster Session A - Molecular Medicine 1.
Veres-Székely, Apor, PhD
KYS71E
Pediatric Center, Semmelweis University; HUN-REN-SU Pediatrics and Nephrology Research Group
+36 1 459 1500/52710
veres-szekely.apor@semmelweis.hu
Optimization of Sirius Red-Based Microplate Assay to Investigate Collagen Production In Vitro
Apor Veres-Székely1, Csenge Szász2, Domonkos Pap1, Beáta Szebeni1, Péter Bokrossy2, László Őrfi3, Attila J. Szabó1, Ádám Vannay1
1: Pediatric Center, Semmelweis University; HUN-REN-SU Pediatrics and Nephrology Research Group
2: Pediatric Center, Semmelweis University
3: Department of Pharmaceutical Chemistry, Semmelweis University; Vichem Chemie Ltd.
Poszter
Poster Session A - Molecular Medicine 1.
Hungarian
Molecular Medicine
Introduction: Tissue fibrosis is characterized by chronic fibroblast activation and consequently excessive accumulation of collagen-rich extracellular matrix. In vitro microplate-based assays are essential to investigate the underlying mechanism and the effect of antifibrotic drugs.
Method: In this study, in the absence of a gold-standard method, we optimized a simple, cost-effective, Sirius Red-based colorimetric measurement to determine the collagen production of fibroblasts grown on 96-well tissue culture plates.
Results: Based on our findings, the use of a serum-free medium is recommended to avoid aspecific signals, while ascorbate supplementation increases the collagen production of fibroblasts. The cell-associated collagens can be quantified by Sirius Red staining in acidic conditions followed by alkaline elution. Immature collagens can be precipitated from the culture medium by acidic Sirius Red solution, and after subsequent centrifugation and washing steps, their amount can be also measured. Increased attention has been paid to optimizing the assay procedure, including incubation time, temperature, and solution concentrations.
Conclusion: The resulting assay shows high linearity and sensitivity and could serve as a useful tool in fibrosis-related basic research as well as in preclinical drug screening.
Funding: This research was founded by the National Research, Development and Innovation Office (NKFIH), K-142728; Semmelweis University, TKP2021-EGA-24, STIA-KFI-2021; Hungarian Research Network, ELKH-POC-2022-024, the New National Excellence Program of the Ministry for Culture and Innovation from the Source of the National Research, Development and Innovation Fund, ÚNKP-23-3-I-SE-36, ÚNKP-23-3-I-SE-42, ÚNKP-23-4-II-SE-29, ÚNKP-23-5-SE-15; Hungarian Academy of Sciences, János Bolyai Research Scholarship.
Semmelweis University
-
I do not give consent to the publication of my abstract on the website of the congress.
Szabad
elfogadva
poszter
nem rendelkezett róla
2965
15:00
15:03